At the time of writing, Bristol-Myers Squibb Co [BMY] stock is trading at $48.72, up 3.09%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BMY shares have gain 6.87% over the last week, with a monthly amount glided 11.90%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Bristol-Myers Squibb Co [NYSE: BMY] stock has seen the most recent analyst activity on August 05, 2025, when Daiwa Securities downgraded its rating to a Neutral but kept the price target unchanged to $42 for it. On April 22, 2025, Cantor Fitzgerald initiated with a Neutral rating and assigned a price target of $55 on the stock. Jefferies upgraded its rating to a Buy but stick to its price target of $70 on December 16, 2024. In a note dated November 13, 2024, Daiwa Securities upgraded an Outperform rating on this stock.
For the past year, the stock price of Bristol-Myers Squibb Co fluctuated between $42.52 and $63.33. Currently, Wall Street analysts expect the stock to reach $63 within the next 12 months. Bristol-Myers Squibb Co [NYSE: BMY] shares were valued at $48.72 at the most recent close of the market. An investor can expect a potential return of 29.31% based on the average BMY price forecast.
Analyzing the BMY fundamentals
According to Bristol-Myers Squibb Co [NYSE:BMY], the company’s sales were 48.03B for trailing twelve months, which represents an -0.97% plunge. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.17%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.35 and Total Capital is 0.2. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 2.75.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 47.87 points at the first support level, and at 47.01 for the second support level. However, for the 1st resistance point, the stock is sitting at 49.16, and for the 2nd resistance point, it is at 49.59.
Ratios To Look Out For
It is important to note that Bristol-Myers Squibb Co [NYSE:BMY] has a current ratio of 1.27. As well, the Quick Ratio is 1.17, while the Cash Ratio is 0.56. Considering the valuation of this stock, the price to sales ratio is 2.06, the price to book ratio is 5.35 and price to earnings (TTM) ratio is 16.45.
Transactions by insiders
Recent insider trading involved Elkins David V, EVP, Chief Financial Officer, that happened on Sep 02 ’25 when 56000.0 shares were sold. Officer, Elkins David V completed a deal on Sep 02 ’25 to buy 56000.0 shares. Meanwhile, EVP, Corporate Affairs Short Bartie Wendy sold 378.0 shares on Aug 02 ’25.
